MEDP · Medpace Holdings, Inc. · Insider Trading

The transaction(s) reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.20. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transaction(s) reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $625.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $637.48. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $632.815. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $625.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $622.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $623.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $622.84. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The option vested in full on October 27, 2025.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The option vested in full on May 13, 2021.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $617.73 to $618.43. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $620.54. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.89. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.25. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $628.685. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The option vested in full on February 15, 2026.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $606.20 to $626.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The option vested in full on 05/14/2022.

The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $608.30 to $609.62. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The option vested in full on 05/13/2021.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $601.29 to $611.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The option vested in full on 05/18/2023.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.345 to $600.47. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $603.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.09 to $608.185. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $602.73. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The option vested in full on May 13, 2021.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $600.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $603.495. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

On November 28, 2025, the Reporting Person was granted 113 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

On November 28, 2025, the Reporting Person was granted 130 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.